Navigation Links
Human guinea pigs wary of high-paying medical trials
Date:12/4/2009

  • More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participation.

  • Research institutions view payments to volunteers as compensation for time and expenses; not as compensation for potential risks related to participating in the experiments.

  • A new study finds that volunteers have a very different view of clinical trial compensation. High-paying research studies raise a red flag for human guinea pigs and signal high levels of risk.

The findings from a study published this month by the journal Social Science and Medicine have implications for informed consent in human subjects research and the debate over research participation incentives.

Cynthia Cryder, assistant professor of Marketing at the Olin Business School, Washington University in St. Louis, is the lead author of the study, "Informative Inducement: Study Payment as a Signal of Risk"*. Her co-authors are Alex John London and George Loewenstein at Carnegie Mellon University and Kevin G. Volpp at the University of Pennsylvania School of Medicine and the Wharton School.

"At a big-picture level, what stands out from these results is that research participants do not just consider participation payments as an incentive to be traded off for their time." Cryder explains. "They actually infer information about the study itself from the participation payment."

Cryder and colleagues conducted three experiments to measure people's interest in participating in potentially risky research studies, their perception of the risk associated with those studies and how payment amounts affected their interest and perceptions.

Experiments for the study were conducted with an online nationwide sample or a sample from a northeastern U.S. city in 2007-2008.

The study finds that while high pay is a real incentive for people to participate in clinical trials, it also increases the "perceived risk" of the trial and the time potential volunteers spend researching and viewing information about risks related to the trial.

"Specifically in our experiments," Cryder explains, "they [participants] judge studies that offer high payments to be riskier than identical studies that offer low payments."

George Loewenstein, the Herbert A. Simon Professor of Economics and Psychology at Carnegie Mellon and co-author of the study, says these findings contradict some of the common guidelines used for establishing participation incentives:

"Most organizations that do research prohibit participation payments that substantially exceed compensation for time and expenses. The fear is that people will be overly tempted by high payments to take excessive risks. Our research challenges this common practice. It suggests that people assume that studies that don't pay much aren't risky."

The study concludes that there is a "mismatch" between current research guidelines for setting compensation levels and the assumptions participants make about the levels of pay and risk. Loewenstein explains:

"Contrary to the assumption that high payments are excessively tempting, our research suggests that they alert subjects to potential risk and make them more vigilant about protecting themselves. An added bonus of high payments is that it is ethically sensible for people to be adequately compensated when they do, in fact, incur risks."

The authors of the study believe their findings should contribute to the debate over research participation incentives and informed consent. The way potential human subjects interpret payment, risk and information about clinical trials as documented in the Cryder et al paper sheds new light on the role of the human subjects in research.


'/>"/>

Contact: Melody Walker
melody_walker@wustl.edu
314-935-5202
Washington University in St. Louis
Source:Eurekalert

Related medicine news :

1. Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee
2. The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH
3. The therapeutic benefits of the human-animal bond
4. Bono and Wyclef Jean Receive RFK Center for Justice & Human Rights Ripple of Hope Award
5. Coal Pollution Damages Human Health at Every Stage of Coal Life Cycle, Reports Physicians for Social Responsibility
6. Human Pheromone Sciences Announces Third Quarter Results
7. Physicians for Human Rights Offers Training in Crime Scene Documentation
8. NIAID announces new human immunology research awards to help fight emerging infectious diseases
9. Not What the Doctor Ordered: Rapid Environmental Change Threatens the Foundations of Human Health
10. Precuneus region of human and monkey brain is divided into 4 distinct regions
11. NovaBays Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... ... CURE Media Group , the nation’s leading digital and print media ... Angels to expand outreach and emotional support for patients of all ages battling ... lifeline to patients and families facing the challenges of cancer diagnosis and treatment,” said ...
(Date:5/5/2016)... ... May 05, 2016 , ... If you don’t mind a bit ... skin, you may want to consider a treatment that some have called the next ... P.C. , Microneedling, also known as skin needling, is a procedure using a ...
(Date:5/5/2016)... ... ... Dermatologic surgeons performed nearly 10 million medically necessary and cosmetic procedures in ... The results of the 2015 ASDS Survey on Dermatologic Procedures released today reveal a ... growing popularity of soft-tissue fillers and body sculpting procedures. , For the fourth ...
(Date:5/5/2016)... ... May 05, 2016 , ... MAP Health Management, LLC, ... that Enlightened Solutions has joined the Premier Outcomes-Driven Provider Network. By becoming a ... their patients being treated for substance use. , Enlightened Solutions was founded by ...
(Date:5/5/2016)... GA (PRWEB) , ... May 05, 2016 , ... Liposuction ... (FDRS) 2016 Conference in St. Louis, Missouri at the Marriot St. Louis Airport Hotel. ... Byrd was chosen to address the conference about her unique specialization in treating Lipedema. ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Actinic Keratosis Market ... to their offering.       (Logo: ... Keratosis Market and Competitive Landscape Highlights 2016, ... products, Actinic Keratosis epidemiology, Actinic Keratosis market ...
(Date:5/3/2016)... , May 4, 2016 ... 154 pages, profiling 09 key companies and supported ... professional and in-depth study on the current state ... overview of the industry including definitions, classifications, applications ... analysis is provided for the international market including ...
(Date:5/3/2016)... May 4, 2016 Research and ... Cancer Stem Cell Therapy Market Outlook 2020" report ... ) , ,Recombinant technology has improved significantly in ... to be developed in coming years. Many cancer drugs ... stem cell therapies are also expected to be developed ...
Breaking Medicine Technology: